Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems

A process is described for preparing a compound of Formula (1.3.0): comprising: establishing a reaction mixture consisting of in an aprotic solvent; in the presence of a strong base in solid form selected from the group consisting of sodium hydroxide, NaOH; and potassium hydroxide, KOH; - and option...

Full description

Saved in:
Bibliographic Details
Main Authors LAMBERT, JOHN FRANCIS, NORRIS, TIMOTHY, HNATOW, MEGAN ELIZABETH
Format Patent
LanguageEnglish
French
German
Published 07.03.2001
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A process is described for preparing a compound of Formula (1.3.0): comprising: establishing a reaction mixture consisting of in an aprotic solvent; in the presence of a strong base in solid form selected from the group consisting of sodium hydroxide, NaOH; and potassium hydroxide, KOH; - and optionally - in the presence of a catalytic amount of cesium carbonate, Cs2CO3, or of a phase transfer catalyst, especially a quaternary ammonium salt or a phosphonium salt - followed by - heating said reaction mixture under a nitrogen atmosphere; whereby there is produced a compound of Formula (1.3.0); and in a preferred embodiment the aprotic solvent is DMSO, the strong base in solid form is NaOH in powder or pellet form, and the phase transfer catalyst is tetra-n-butylammonium chloride (TBAC), which is used to prepare a preferred compound, useful as a 5-lipoxygenase inhibitor, of the formula: and especially the substantially pure methanesulfonate salt thereof.
Bibliography:Application Number: EP20000307440